RLFTY (MindMaze Therapeutics Holding) EV-to-FCF: (As of Jul. 02, 2026)


RLFTY MindMaze Therapeutics Holding SA RLFTY
11 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is MindMaze Therapeutics Holding EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, MindMaze Therapeutics Holding's Enterprise Value is $56.95 Mil. MindMaze Therapeutics Holding does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate MindMaze Therapeutics Holding's EV-to-FCF at this moment.

The historical rank and industry rank for MindMaze Therapeutics Holding's EV-to-FCF or its related term are showing as below:

RLFTY' s EV-to-FCF Range Over the Past 10 Years
Min: -3.66   Med: 0   Max: 0
Current: -3.66
RLFTY's EV-to-FCF is ranked worse than
100% of 331 companies
in the Biotechnology industry
Industry Median: 15.9 vs RLFTY: -3.66

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-02), MindMaze Therapeutics Holding's stock price is $0.4225. MindMaze Therapeutics Holding does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate MindMaze Therapeutics Holding's PE Ratio (TTM) at this moment.

MindMaze Therapeutics Holding  (OTCPK:RLFTY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

MindMaze Therapeutics Holding's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.4225/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

MindMaze Therapeutics Holding EV-to-FCF Related Terms

MindMaze Therapeutics Holding EV-to-FCF Historical Data

* Premium members only.

The historical data trend for MindMaze Therapeutics Holding's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindMaze Therapeutics Holding EV-to-FCF Chart

MindMaze Therapeutics Holding Annual Data
Trend Dec24 Dec25
EV-to-FCF
0.00 -46.37

MindMaze Therapeutics Holding Semi-Annual Data
Dec24 Dec25
EV-to-FCF 0.00 0.00

RLFTY vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, MindMaze Therapeutics Holding's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindMaze Therapeutics Holding EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindMaze Therapeutics Holding's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where MindMaze Therapeutics Holding's EV-to-FCF falls into.


RLFTY
11GF Score
MindMaze Therapeutics Holding SA RLFTY
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindMaze Therapeutics Holding EV-to-FCF Calculation

MindMaze Therapeutics Holding's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=56.946/
=

MindMaze Therapeutics Holding Business Description

Other Exchanges MMTXz:UKMMTX:Switzerland
Address Avenue de Secheron 15, Geneva, CHE, 1202
MindMaze Therapeutics Holding SA is a Swiss-based, commercial-stage biopharmaceutical and neurotechnology company. The company develops and commercializes digital treatments for neurological diseases and brain disorders. Its technology platform integrates software, sensors, and telehealth, and its solutions are used in clinical and home settings internationally. The company has developed evidence-based, next-generation neurotherapeutics that provide evidence-based motor and cognitive treatments to redefine clinical outcomes in patients with neurological disease and brain disorders. The company also manages Relief's existing portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.
11GF Score

Get the complete analysis for RLFTY

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price